Dr. Jensen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 Martha Jefferson Drive
Charlottesville, VA 22911Phone+1 434-654-8960
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiology-Diagnostic, 1989 - 1990
- Virginia Commonwealth University Health SystemResidency, Radiology-Diagnostic, 1984 - 1987
- Virginia Commonwealth University Health SystemResidency, Neurology, 1982 - 1984
- Virginia Commonwealth University School of MedicineClass of 1982
Certifications & Licensure
- VA State Medical License 1984 - 2026
- FL State Medical License 2018 - 2020
- American Board of Radiology Diagnostic Radiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 6 citationsA DELPHI consensus statement on antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of mechanical thrombectomy.Mayank Goyal, Kirill Orlov, Mary E Jensen, Allan Taylor, Charles Majoie
Neuroradiology. 2021-04-01 - Correction to: A DELPHI consensus statement on antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of mechanical thrombe...Mayank Goyal, K Orlov, Mary E. Jensen, Allan Taylor, Charles B. L. M. Majoie
Neuroradiology. 2021-01-01 - 16 citationsConsiderations for Antiplatelet Management of Carotid Stenting in the Setting of Mechanical Thrombectomy: A Delphi Consensus StatementMayank Goyal, S. Yoshimura, Geneviève Milot, Jens Fiehler, Mahesh V Jayaraman
AJNR. American Journal of Neuroradiology. 2020-12-01
Press Mentions
- FDA Panel: Neuronix Alzheimer’s Therapy Fails to Prove EfficacyMarch 22nd, 2019
- Exotic Trends in New MedicineJune 30th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: